Efficacy and safety of fludarabine/cyclophosphamide (FC) as front-line treatment of CLL. Final results of a phase II clinical trial in a single center.

被引：0
|
作者：
Marin-Niebla, A [1 ]
Rios-Herranz, E [1 ]
Rodriguez, JM [1 ]
Nunez, R [1 ]
Herrera, A [1 ]
Parody, R [1 ]
Espigado, I [1 ]
机构：
[1] Hosp Virgen Rocio, Seville, Spain
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4826.4826
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4826
引用
收藏
页码：289B / 289B
页数：1
相关论文
共 50 条
  • [21] Clinical pathway for enhanced recovery after surgery for gastric cancer: A prospective single-center phase II clinical trial for safety and efficacy
    Roh, Chul Kyu
    Son, Sang-Yong
    Lee, Sook Young
    Hur, Hoon
    Han, Sang-Uk
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (04) : 662 - 669
  • [22] Preliminary results from a phase II clinical trial assessing the safety and efficacy of pembrolizumab in the treatment of highgrade cervical intraepithelial neoplasia
    Jimenez, Maria Garcia
    Lai, Tiffany
    Ferullo, Sylvia
    Walchonski, Jessica
    Chang, Yixuan
    Salani, Ritu
    Glaspy, John
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S289 - S290
  • [23] Phase II trial of alternate schedule of chemotherapy as front-line treatment in metastatic non-small cell lung cancer (NSCLC): A single-centre experience
    Lopez Castro, R.
    Martin, G.
    Seijas, R.
    Bellido, L.
    del Barco, E.
    Garcia, R.
    Martin, T.
    Castro, E.
    Leno, R.
    Cruz, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Comment on "Clinical pathway for enhanced recovery after surgery for gastric cancer: A prospective single-center phase II clinical trial for safety and efficacy"
    Hu, Qiang
    Yang, Xiyin
    JOURNAL OF SURGICAL ONCOLOGY, 2020, 122 (02) : 360 - 360
  • [25] Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors
    Min, Limei
    Wang, Xiaolu
    Chen, Anni
    Zhou, Yingling
    Ge, Yuchen
    Dai, Juanjuan
    Chang, Xiaofeng
    Sun, Wu
    Liu, Qin
    Zhou, Xia
    Tian, Manman
    Kong, Wentao
    Zhu, Junmeng
    Shen, Jie
    Liu, Baorui
    Li, Rutian
    FUTURE ONCOLOGY, 2024, 20 (17) : 1139 - 1149
  • [26] Consolidation Therapy with Subcutaneous Alemtuzumab After Induction Treatment with Oral FC (Fludarabine and Cyclophosphamide) in Previously Untreated Patients Aged 65-70 Years with Advanced Stage Chronic Lymphocytic Leukemia (CLL): Final Results of a Phase II Study From the FCGCLL/WM
    Delmer, Alain
    Tournilhac, Olivier
    Lepretre, Stephane
    Cazin, Bruno
    Feugier, Pierre
    Dreyfus, Brigitte
    Mahe, Beatrice
    Leporrier, Michel
    Michallet, Anne-Sophie
    Jaccard, Arnaud
    Divine, Marine
    Levy, Vincent
    Cymbalista, Florence
    Letestu, Remi
    BLOOD, 2011, 118 (21) : 1667 - 1667
  • [27] Thalidomide (T) in combination with fludarabine (F) as initial therapy for patients (pts) with treatment naive chronic lymphocytic leukemia (CLL): Preliminary results of a phase I/II clinical trial
    Chanan-Khan, AA
    Miller, KC
    Marshall, P
    Padmanabhan, S
    Brady, W
    Bernstein, ZP
    Wallace, P
    Czuczman, MS
    BLOOD, 2005, 106 (11) : 834A - 834A
  • [28] The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
    Huang, Nai-si
    Wei, Wen-jun
    Xiang, Jun
    Chen, Jia-ying
    Guan, Qing
    Lu, Zhong-wu
    Ma, Ben
    Sun, Guo-hua
    Wang, Yu-long
    Ji, Qing-hai
    Wang, Yu
    THYROID, 2021, 31 (12) : 1808 - 1813
  • [29] Efficacy and safety profile of lurbinectedin in second-line SCLC patients: Results from a phase II single-agent trial.
    Paz-Ares, Luis G.
    Trigo Perez, Jose Manuel
    Besse, Benjamin
    Moreno, Victor
    Lopez, Rafael
    Angeles Sala, Maria
    Ponce Aix, Santiago
    Marcelo Fernandez, Cristian
    Siguero, Mariano
    Maria Kahatt, Carmen
    Zeaiter, Ali Hassan
    Zaman, Khalil
    Boni, Valentina
    Arrondeau, Jennifer
    Martinez Aguillo, Maite
    Delord, Jean-Pierre
    Awada, Ahmad
    Kristeleit, Rebecca Sophie
    Olmedo Garcia, Maria Eugenia
    Subbiah, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma: A phase Ib/II clinical trial
    Bai, L.
    Bai, Y.
    Huang, M.
    Shao, G.
    Song, L.
    Sun, M.
    Wang, W.
    Wu, J.
    Xu, A.
    Huang, L.
    Liu, T.
    Liu, W.
    Wang, Z. M.
    Li, B.
    Xia, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S595 - S595
12345